Epstein-Barr virus clonality in lymphomas occurring in patients with rheumatoid arthritis

Arthritis and Rheumatism

Volumn 39, Issue 4, 1996, Pages 638-642

  Van De Rijn, Matthijs ^a,d   Cleary, Michael L ^b   Variakojis, Daina ^c   Warnke, Roger A ^b   Chang, Pearl P ^b   Kamel, Onsi W ^b  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d 6 Founders Pavilion ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYCHLOROQUINE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE;

ARTICLE; B CELL LYMPHOMA; CASE REPORT; EPSTEIN BARR VIRUS; FEMALE; GENE REARRANGEMENT; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; LYMPHOCYTE SUBPOPULATION; LYMPHOMA; MOLECULAR CLONING; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; VIRUS TRANSFORMATION;

AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; B-LYMPHOCYTES; CLONE CELLS; FEMALE; GENE REARRANGEMENT, T-LYMPHOCYTE; HERPESVIRUS 4, HUMAN; HUMANS; LYMPHOMA, LARGE-CELL, DIFFUSE; MIDDLE AGED;

EID: 0030005142     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780390415     Document Type: Article

References (14)

1. Kamel OW, van de Rijn M, Weiss LM, Del Zoppo GJ, Hench PK, Robbins BA, Montgomery PG, Warnke RA, Dorfman RF: Reversible Epstein-Barr virus-associated lymphomas occurring in the setting of methotrexate therapy for rheumatoid arthritis and dermatomyositis. New Engl J Med 328:1317-1321, 1993
2. Starzl TE, Naiesnik MA, Porter KA, Ho M, Iwatsuki S, Griffith BP, Rosenthal JT, Hakala TR, Shaw BJ, Hardesty RL, Jaffe R, Bahnson HT: Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet 1:583-587, 1984
3. Kamel OW, van de Rijn M, LeBrun DP, Weiss LM, Warnke RA, Dorfman RF: Lymphoid neoplasms in patients with rheumatoid arthritis and dermatomyositis: frequency of Epstein-Barr virus and other features associated with immunosuppression. Hum Pathol 25:638-643, 1994
4. Gelb AB, van de Rijn M, Cornbleet JP, Kamel OW, Horoupian DS, Cleary ML, Warnke RW: Epstein-Barr virus associated natural killer-large granular lymphocyte leukemia. Hum Pathol 25:953-960, 1994
5. Cleary ML, Nalesnik MA, Shearer WT, Sklar J: Clonal analysis of transplant-associated lymphoproliferations based on the structure of the genomic termini of the Epstein-Barr virus. Blood 72:349-352, 1988
6. Staal SP, Ambinder R, Beschorner WE, Hayward GS, Mann R: A survey of Epstein-Barr virus DNA in lymphoid tissue: frequent detection in Hodgkin's disease. Am J Clin Pathol 91:1-5, 1989
7. Zijlmans JMJM, van Rijthoven AWAM, Kluin PM, Jiwa NM, Dijkmans BAC, Kluin-Nelemans JC: Epstein-Barr virus-associated lymphoma in a patient with rheumatoid arthritis treated with cyclosporine (letter). N Engl J Med 326:1363, 1992
8. Kingsmore SF, Hall BD, Allen NB, Rice JR, Caldwel DS: Association of methotrexate, rheumatoid arthritis and lymphoma: report of 2 cases and literature review. J Rheumatol 19:1462-1465, 1992
9. Ellman MH, Hurwitz H, Thomas C, Kozloff M: Lympoma developing in a patient with rheumatoid arthritis taking low dose weekly methotrexate. J Rheumatol 18:1741-1743, 1991
10. Shiroky JB, Frost A, Skelton JD, Haegert DG, Newkirk MM, Neville C: Complications of immunosuppression associated with weekly low dose methotrexate. J Rheumatol 18:1172-1175, 1991
11. Ferraccioli GF, Casatta L, Bartoli E, De Vita S, Dolcetti R, Boiocchi M, Carbone A: Epstein-Barr virus-associated Hodgkin's lymphoma in a rheumatoid arthritis patient treated with methotrexate and cyclosporin A. Arthritis Rheum 38:867-868, 1995
12. Tosato G, Magrath IT, Blaese RM: T cell-mediated immuno-regulation of Epstein Barr virus (EBV)-induced B lymphocyte activation in EBV-seropositive and EBV-seronegative individuals. J Immunol 128:575-579, 1982
13. Bailin PL, Tindall JP, Roenigk HH, Hogan MD: Is methotrexate therapy for psoriasis carcinogenic? A modified retrospective analysis. JAMA 232:359-362, 1975
14. Lipsky PE: Immunosuppression by D-penicillamine in vitro: inhibition of human T lymphocyte proliferation by copper- or ceruloplasmin-dependent generation of hydrogen peroxide and protection by monocytes. J Clin Invest 73:53-65, 1984